LeMaitre Vascular, a provider of innovative medical devices for the treatment of peripheral vascular disease, announced the terms for its IPO on Tuesday. The company plans to offer 6 million shares at a range of $8-$10. The deal has a proposed market cap of $146 million. Goldman Sachs, CIBC World Markets, Cowen & Company and Thomas Weisel are set to manage the deal. Timing has yet to be announced.
